Abstract 4305
Background
Pulmonary lymphoepithelioma-like carcinoma (PLELC) is a rare Epstein-Barr virus (EBV) associated cancer, histologically indistinguishable from nasopharyngeal carcinoma (NPC). Somatostatin receptor type 2 (SSTR2) is a bonafide theranostic target in neuroendocrine tumour. It is also demonstrably expressed in NPC, with autoradiography and positron emission tomography (PET). SSTR2 expression has not been reported in PLELC. In this study, we aimed to investigate SSTR2 expression and its co-localization with EBV positive PLELC cells using immunohistochemistry (IHC); and to investigate the clinical significance of SSTR2 in PLELC.
Methods
Clinical demographics including age, gender, TNM staging, EBV titre, smoking status, survival and treatment regime were collected. Archival formalin fixed, paraffin embedded (FFPE) tissue from patients diagnosed with PLELC between 2003 and 2016 at National Cancer Centre Singapore were retrieved and studied retrospectively. IHC staining for SSTR2 and Epstein-Barr encoding region in-situ hybridisation (EBER-ISH) were performed using a dual-staining technique.
Results
We report clinical data and dual staining from 20 PLELC patients. The median age at diagnosis was 56.5; 80% (16/20) of the patients were female; all non-smokers (except 3 with unknown status); 55% (11/20) of the patients had stage IV disease and the rest stage I-IIIB. High serum EBV titres were also noted in PLELC patients. Sixteen out of 20 patients (80%) stained positive for SSTR2 on IHC. SSTR2 expression co-localised with EBER positive cells. Nine out of 11 (82%) patients with stage IV PLELC stained positive for SSTR2 while 7 out of 9 (78%) stage I-III disease stained positive. Two year OS by SSTR2 status is 100% in SSTR2 negative and 65.2% (CI 35.1, 84.0) in SSTR2 positive patients, p = 0.467 by Log Rank Test. Two year OS by stage is 85.7% (CI 33.4, 85.7) for stage I-III and 63.6% (CI 29.7, 84.5) for stage IV disease, p = 0.014.
Conclusions
In PLELC, high levels of SSTR2 IHC expression is reported with co-localisation with EBV infected cells. A high proportion of stage IV patients have SSTR2 positive tumours. These patients have limited treatment options. This study opens up the possibility of using SSTR2 theranostics for these patients.
Clinical trial identification
Legal entity responsible for the study
National Cancer Centre Singapore.
Funding
National Cancer Centre Singapore Research Fund.
Editorial Acknowledgement
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
4162 - ODM-207 - a novel BET bromodomain inhibitor with antitumor activity in nonclinical models of ER+ breast cancer
Presenter: Anu Moilanen
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
3747 - HER2-positive breast cancer resistance to trastuzumab is associated with metabolic switch.
Presenter: Roman Dubianski
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
4688 - Combination treatment with the PARP inhibitor niraparib and chemotherapeutics in a preclinical model of KRAS/BRAF mutated colorectal cancer cell lines across the four Consensus Molecular Subtypes.
Presenter: Pietro Paolo Vitiello
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
498 - Exosomal microRNA-32-5p induces multidrug resistance in hepatocellular carcinoma via the PI3K/Akt pathway.
Presenter: Xiao Fu
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
3731 - Effect of the polymorphism rs2470893 of the CYP1A1 gene on ovarian and endometrial cancer in Mediterranean women
Presenter: Judith Begona Ramirez Sabio
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
1215 - Cisplatin in NIPEC or HIPEC?
Presenter: Ivan Alvovsky
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
2738 - Matrix metalloproteinase-mediated regulation of programmed-death ligand in the human head and neck squamous cell carcinoma microenvironment
Presenter: MARIKO HIRAI
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
2190 - Trametinib synergizes with dexamethasone in KRAS-mutant myeloma cell lines through modulation of NDRG1 and induction of apoptosis
Presenter: Priya Sriskandarajah
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
4482 - Functional inhibition of TGF-_ in colorectal cancer cells and its interaction with AXL receptor
Presenter: Davide Ciardiello
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
624 - Isoform-specific AKT Inhibition Differentially Affects Cell Functions in Pancreatic Adenocarcinoma
Presenter: Hugo Arasanz
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract